Department of Surgery, The Alpert Medical School, Brown University, Rhode Island Hospital, Providence, Rhode Island, USA.
J Surg Oncol. 2010 Dec 15;102(8):1002-8. doi: 10.1002/jso.21694.
Fifty percent of patients with colorectal cancer will develop metastases at some time during their disease, with the liver being the most common site. Recent advances in the treatment of metastatic colorectal cancer have led to a change in treatment paradigm. What follows is a review of the surgical management of hepatic colorectal metastases responding to neoadjuvant chemotherapy. In addition, the complexity of treating patients with "disappearing" colorectal liver metastases is discussed.
50%的结直肠癌患者在疾病的某个阶段会发生转移，肝脏是最常见的转移部位。转移性结直肠癌治疗的最新进展改变了治疗模式。以下是对新辅助化疗后肝转移灶可切除的结直肠癌患者的手术治疗管理的回顾。此外，还讨论了治疗“消失”结直肠肝转移患者的复杂性。
Zotero 插件